Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ULTRALIFE CORP Director's Dealing 2025

Nov 19, 2025

34105_dirs_2025-11-19_a428c1fa-8408-42c5-9718-47267d9f9a96.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2025-11-19

Reporting Person: Manna Michael Edward (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-11-19 Common Stock; $.10 par value P 1000 $4.943 Acquired 23874 Direct
2025-11-19 Common Stock; $.10 par value P 1000 $4.99 Acquired 24874 Direct